CTSNet Podcasts podcast

The Beat With Joel Dunning Ep. 174: Surgical Treatment of Atrial Fibrillation

0:00
28:13
15 Sekunden vorwärts
15 Sekunden vorwärts

This week on The Beat, CTSNet Editor-in-Chief Joel Dunning spoke with James Cox, Professor of Cardiac Surgery at the Feinberg School of Medicine at Northwestern Medicine in Chicago, Illinois, USA, and Patrick McCarthy, Executive Director of the Bluhm Cardiovascular Institute, Heller-Sacks Professor of Cardiothoracic Surgery, Professor of Cardiac Surgery at the Feinberg School of Medicine at Northwestern Medicine in Chicago, Illinois, USA, about the surgical treatment of atrial fibrillation (AF).

Chapters 

00:00 Intro 

01:32 CMS NCD on TAVR Heart Team 

04:22 JANS 1, Tarlatamab Clinical Responses  

05:23 JANS 2, No Stent Hybrid Revasc Robotic TECAB 

06:45 JANS 3, STS Risk Model for SAVR After TAVR 

08:43 JANS 4, Surgical Exposure Bilat Lung Transplant 

10:12 JANS 5, Heart Drug Failure Challenges Theory 

12:53 Video 1, Off-Pump TECAB da Vinci 5 

14:00 Video 2, Aortic Uncrossing, Circumflex Aorta 

14:50 Video 3, Ross Face-Off, Twin Root Replacement 

15:57 Dr. Cox & McCarthy, Atrial Fib Surgery 

27:00 Upcoming Events 

They discussed the vital importance of surgical treatment for AF, the current underutilization of these procedures, the rationale for why AF should be treated, and abating AF. Furthermore, they explored the role of AF as a quality marker, the necessity for surgeons to develop proficiency in these techniques, and the importance of resident training on this procedure. Additionally, they reviewed the benefits of devices for AF, examined arrythmias in general, and their newly published textbook on the subject.

Joel also highlights recent JANS articles on the Society of Thoracic Surgeons risk model for surgical aortic valve replacement after transcatheter aortic valve replacement, a promising heart drug failing which challenged a long-held theory of disease, clinical responses to tarlatamab among patients with pulmonary carcinoid, hybrid revascularization with robotic totally endoscopic coronary bypass and stents, and the effect of surgical exposure on outcomes in bilateral lung transplantation.

In addition, Joel explores off-pump totally endoscopic coronary artery bypass using the da Vinci 5, aortic uncrossing procedure for circumflex aorta, and a twin root replacement combined with coronary artery bypass after a previous Ross procedure.

Before closing, Joel highlights upcoming events in CT surgery.

JANS Items Mentioned

  1. The Society of Thoracic Surgeons Risk Model for Surgical Aortic Valve Replacement After Transcatheter Aortic Valve Replacement
  2. A Promising Heart Drug Fails, Challenging a Long-Held Theory of Disease
  3. Clinical Responses to Tarlatamab Among Patients With Pulmonary Carcinoid
  4. Hybrid Revascularization With Robotic Totally Endoscopic Coronary Bypass and Stents: What Are the Outcomes When The Stent Does Not Happen?
  5. Effect of Surgical Exposure on Outcomes in Bilateral Lung Transplantation: Insight From the International Multicenter Extracorporeal Life Support in Lung Transplantation Registry

CTSNet Content Mentioned

  1. Off-Pump Totally Endoscopic Coronary Artery Bypass Using the da Vinci 5: Closed-Chest Stabilizer Technique
  2. Aortic Uncrossing Procedure for Circumflex Aorta
  3. Ross “Face-Off”: Twin Root Replacement

Other Items Mentioned

  1. Oral Board AI Simulator
  2. CTSNet Innovation Video Competition
  3. Career Center
  4. CTSNet Events

 

Disclaimer The information and views presented on CTSNet.org represent the views of the authors and contributors of the material and not of CTSNet. Please review our full disclaimer page here.

Weitere Episoden von „CTSNet Podcasts“